REGRESSION OF CARDIAC-HYPERTROPHY AND CARDIOPROTECTION BY ANGIOTENSIN-II RECEPTOR ANTAGONIST TCV-116

被引：0
|
作者：
SHIOJIMA, I [1 ]
YAMAZAKI, T [1 ]
KOJIMA, M [1 ]
MAEMURA, K [1 ]
KURIHARA, Y [1 ]
NAGAI, R [1 ]
机构：
[1] UNIV TOKYO,TOKYO 113,JAPAN
来源：
CIRCULATION | 1993年 / 88卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [11] CARDIOPROTECTIVE EFFECT OF THE ANGIOTENSIN-II TYPE-1 RECEPTOR ANTAGONIST TCV-116 ON ISCHEMIA-REPERFUSION INJURY
    YOSHIYAMA, M
    KIM, SK
    YAMAGISHI, H
    OMURA, T
    TANI, T
    YANAGI, S
    TODA, I
    TERAGAKI, M
    AKIOKA, K
    TAKEUCHI, K
    TAKEDA, T
    AMERICAN HEART JOURNAL, 1994, 128 (01) : 1 - 6
  • [12] EFFECTS OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST, TCV-116, ON BLOOD-PRESSURE AND THE RENIN-ANGIOTENSIN SYSTEM IN HEALTHY-SUBJECTS
    OGIHARA, T
    NAGANO, M
    MIKAMI, H
    HIGAKI, J
    KOHARA, K
    AZUMA, J
    AOKI, T
    HAMANAKA, Y
    CLINICAL THERAPEUTICS, 1994, 16 (01) : 74 - 86
  • [13] The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats
    Y. Nagisa
    A. Shintani
    S. Nakagawa
    Diabetologia, 2001, 44 : 883 - 888
  • [14] The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats
    Nagisa, Y
    Shintani, A
    Nakagawa, S
    DIABETOLOGIA, 2001, 44 (07) : 883 - 888
  • [15] ANGIOTENSIN-II RECEPTOR ANTAGONIST TCV-116 INDUCES REGRESSION OF HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY IN-VIVO AND INHIBITS THE INTRACELLULAR SIGNALING PATHWAY OF STRETCH-MEDIATED CARDIOMYOCYTE HYPERTROPHY IN-VITRO
    KOJIMA, M
    SHIOJIMA, I
    YAMAZAKI, T
    KOMURA, I
    ZOU, YZ
    WANG, Y
    MIZUNO, T
    UEKI, K
    TOBE, K
    KADOWAKI, T
    NAGAI, R
    YAZAKI, Y
    CIRCULATION, 1994, 89 (05) : 2204 - 2211
  • [16] Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats
    Naeshiro, I
    Sato, K
    Chatani, F
    Sato, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 354 (2-3) : 179 - 187
  • [17] EFFECTS OF LOSARTAN, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON CARDIAC-HYPERTROPHY AND THE TISSUE ANGIOTENSIN-II CONTENT IN SPONTANEOUSLY HYPERTENSIVE RATS
    MIZUNO, K
    TANI, M
    HASHIMOTO, S
    NIIMURA, S
    SANADA, H
    WATANABE, H
    OHTSUKI, M
    FUKUCHI, S
    LIFE SCIENCES, 1992, 51 (05) : 367 - 374
  • [18] TCV-116, A NOVEL ANGIOTENSIN-II RECEPTOR ANTAGONIST, PREVENTS INTIMAL THICKENING AND IMPAIRMENT OF VASCULAR FUNCTION AFTER CAROTID INJURY IN RATS
    KAWAMURA, M
    TERASHITA, ZI
    OKUDA, H
    IMURA, Y
    SHINO, A
    NAKAO, M
    NISHIKAWA, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 266 (03): : 1664 - 1669
  • [19] EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST ON CARDIAC-HYPERTROPHY IN DAHL SALT-SENSITIVE RATS
    SUGIMOTO, K
    GOTOH, E
    TAKASAKI, I
    SHIONOIRI, H
    ISHII, M
    HYPERTENSION, 1992, 20 (03) : 419 - 419
  • [20] Quantitation of a new potent angiotensin II receptor antagonist, TCV-116, and its metabolites in human serum and urine
    Miyabayashi, T
    Okuda, T
    Motohashi, M
    Izawa, K
    Yashiki, T
    JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 677 (01): : 123 - 132
12345